American Statistical Association
Situations where individuals are under observation for a specific failure event of interest but may experience other precluding failure event types, or competing risks observations, are ubiquitous in cancer clinical research. The competing risks phenomenon is well known in other areas of medical research and has a long history in other fields such as demography and engineering reliability. While a substantial body of theoretical research addresses conditions under which specific quantities of interest can (or cannot) be estimated, there are a number of practical approaches requiring minimal assumptions and that yield information of particular relevance in cancer natural history and treatment development. In this presentation, some competing risks problems encountered in the conduct of clinical trials in cancer are presented, along with approaches taken and areas where further methodological developments are needed.
|Date:||Wednesday, April 4, 2018|
|Time:||4:00 - 5:00 P.M.|
Memorial Sloan Kettering Cancer Center
Department of Epidemiology and Biostatistics
485 Lexington Avenue
(Between 46th & 47th Streets)
2nd Floor, Conference Room B
New York, New York
**Outside visitors please email email@example.com for building access. You must be on the security list to enter the floor.